Retinal dystrophin transgene and methods of use thereof

Details for Australian Patent Application No. 2005274798 (hide)

Owner The Children's Mercy Hospital

Inventors Gaedigk, Roger; Fitzgerlad-Gustafson, Kathleen; White, Robert

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005274798

PCT Pub. Number WO2006/020184

Priority 60/588,700 16.07.04 US; 60/613,026 24.09.04 US; 11/050,911 04.02.05 US; 60/608,252 09.09.04 US

Filing date 15 July 2005

Wipo publication date 23 February 2006

Acceptance publication date 17 November 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/020184 Priority application(s): WO2006/020184

17 November 2011 Application Accepted

  Published as AU-B-2005274798

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274811-Treatment of skin with light and a benefit agent to mitigate acne

2005274794-Implantable devices and methods for delivering drugs and other substances to treat sinusitis and other disorders